Learning Objectives:

1. To understand the molecular landscape of Gliomas: IDH, BRAF mutations.

2. To explore the latest advancements in targeted therapies: current and emerging targeted therapies.

3. To address the challenges and future directions in precision Neuro-Oncology.

Session date: 
03/12/2025 - 8:00am to 9:00am CDT
Location: 
UT Southwestern Medical Center
Dallas, TX
United States
  • 1.00 AMA
  • 1.00 Attendance

Please login or create an account to take this course.